You are here

Global

White House coronavirus adviser says vaccine companies plan to update shots to address variants

White House coronavirus adviser official discusses plans by  vaccine companies cope with COVID-19 variants

Andy Slavitt, White House senior adviser on the coronavirus response, said vaccine-producing companies plan to update their shots to address variants of the virus.

During a Washington Post live interview Thursday, he said the Pfizer and Moderna vaccines “work well for” the most prominent variant spreading throughout the United States, which is the one first identified in Britain.

He said that while the vaccines appear less effective against the variants first identified in Brazil and South Africa, they do produce some antibodies.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID "Long haulers" --more background on their problems

How many people get ‘long COVID’ – and who is most at risk?

A few months ago, a young athletic guy came into my clinic where I’m an infectious disease physician and COVID-19 immunology researcher. He felt tired all the time, and, importantly to him, was having difficulty mountain biking. Three months earlier, he had tested positive for COVID-19. He is the kind of person you might expect to have a few days of mild symptoms before recovering fully. But when he walked into my clinic, he was still experiencing symptoms of COVID-19 and he could not mountain bike at the level he was able to before.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The difficulties in enrolling teenagers for vaccine test trials.

 

 

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU makes deals to get more vaccines, plans to tackle variants

BRUSSELS (AP) — Amid signs that more infectious coronavirus variants are spreading unchecked across Europe, governments and EU leaders scrambled Wednesday to speed up vaccine efforts that have been hampered by limited supplies and to fund ways to hunt down variants and counter them.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks